Share Twitter LinkedIn Facebook Email Leonard Saltz, MD, Executive Director for Clinical Value and Sustainability, Colorectal Oncology Section, Memorial Sloan Kettering Cancer Center addresses whether current data will change the way we treat colorectal cancer.
KRYSTAL-1: Adagrasib + Cetuximab Promise for KRASG12C Colorectal Cancer – Scott Kopetz, MD [AACR 2024] Colorectal 3 Mins Read
2024 Optimistic Advances in Colorectal Cancer: New Genetic Discoveries & Dancing Colorectal 5 Mins Read
Where do you see the greatest utility of ctDNA testing in patients with solid tumors? Colorectal 1 Min Read